Your browser doesn't support javascript.
loading
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies.
Pascual-Pasto, Guillem; McIntyre, Brendan; Shraim, Rawan; Buongervino, Samantha N; Erbe, Amy K; Zhelev, Doncho V; Sadirova, Shakhnozakhon; Giudice, Anna M; Martinez, Daniel; Garcia-Gerique, Laura; Dimitrov, Dimiter S; Sondel, Paul M; Bosse, Kristopher R.
Afiliación
  • Pascual-Pasto G; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • McIntyre B; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Shraim R; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Buongervino SN; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Erbe AK; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Zhelev DV; Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Sadirova S; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Giudice AM; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Martinez D; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Garcia-Gerique L; Department of Pathology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Dimitrov DS; Immunology, Microenvironment and Metastasis Program, Wistar Institute, Philadelphia, Pennsylvania, USA.
  • Sondel PM; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Bosse KR; Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
J Immunother Cancer ; 10(12)2022 12.
Article en En | MEDLINE | ID: mdl-36460335
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoconjugados / Neuroblastoma Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoconjugados / Neuroblastoma Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido